MCLEAN, Va., Jan. 21 /PRNewswire-FirstCall/ -- MicroStrategy(R) Incorporated (Nasdaq: MSTR), a leading worldwide provider of business intelligence (BI) software, today announced that Dana-Farber Cancer Institute has selected the MicroStrategy Business Intelligence Platform(TM) for clinical operations and clinical research reporting applications. Dana-Farber Cancer Institute is a principal teaching affiliate of the
Dana-Farber will use MicroStrategy for its clinical operations reporting application, which will be used by clinic managers, nurses, disease program administrators, and schedulers to improve their ability to manage patient flow through clinical areas, reduce wait times, optimize clinical processes like pharmacy dispenses and medical records management, and monitor staffing levels. Clinical research assistants, statisticians, doctors, and clinical researchers will use the MicroStrategy-based clinical research reporting application for insights into data that will help them write research papers and grants, identify patients for clinical studies, and better understand treatment outcomes.
"We selected MicroStrategy because we needed a fully integrated business intelligence platform that was reliable, scalable, and easy to use," said John Orechia, Clinical and Research Reporting Team Leader of Dana-Farber Cancer Institute. "With MicroStrategy's robust reporting and intuitive Web interface, our personnel will have access to the information they need to make essential decisions for our organization and our patients."
"We are proud to support Dana-Farber Cancer Institute and its multiple reporting applications," said MicroStrategy's COO Sanju Bansal. "Organizations across the healthcare industry r
|SOURCE MicroStrategy Incorporated|
Copyright©2009 PR Newswire.
All rights reserved